Paul Pennock, head of Weitz & Luxenberg's drug and medical device litigation unit, says, "Weitz & Luxenberg is aggressively investigating the link between Seroquel and diabetes. We have received a flood of inquiries from concerned individuals."
Once heralded as the miracle drug for schizophrenia, Seroquel has recently in the last couple of years has come under scrutiny of the medical community. In 2004, four medical societies named Seroquel as one of six anti-psychotic drugs that are linked with type 2 diabetes complications. Seroquel manufacturers AstraZeneca have been requested by US regulators to include warnings about the risk of elevated blood sugar and diabetes on their US label; however currently their US label for Seroquel does not warn patients and doctors of this known problem and the need to monitor for type 2 diabetes complications.
No comments:
Post a Comment